Suchergebnisse - "Rejeski, Kai"

PubPharm (18)

1

The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL

enthalten in: American journal of hematology | 2023

von Rejeski, K. | Wang, Y. | Albanyan, O. | +17

2

Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL

enthalten in: Blood advances | 2023

von Blumenberg, V. | Busch, G. | Baumann, S. | +24

3

Prognostic value of pre-infusion tumor growth rate for patients with lymphoma receiving chimeric antigen receptor T-cell therapy

enthalten in: Cytotherapy | 2023

von Winkelmann, M. | Blumenberg, V. | Rejeski, K. | +11

4

Immune effector cell-associated hematotoxicity : EHA/EBMT consensus grading and best practice recommendations

enthalten in: Blood | 2023

von Rejeski, K. | Subklewe, M. | Aljurf, M. | +34

CommentIn: Blood. 2023 Sep 7;142(10):859-861. - PMID 37676695

5

The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma

enthalten in: Journal of hematology & oncology | 2023

von Rejeski, K. | Hansen, D. | Bansal, R. | +15

6

Mechanisms of Resistance and Treatment of Relapse after CAR T-cell Therapy for Large B-cell Lymphoma and Multiple Myeloma

enthalten in: Transplantation and cellular therapy | 2023

von Rejeski, K. | Jain, M. | Smith, E.

7

Influence of Adipose Tissue Distribution, Sarcopenia, and Nutritional Status on Clinical Outcomes After CD19 CAR T-cell Therapy

enthalten in: Cancer immunology research | 2023

von Rejeski, K. | Cordas Dos Santos, D. | Parker, N. | +14

CommentIn: Cancer Immunol Res. 2023 Jun 2;11(6):704. - PMID 37264818

8

Shunt dependency in supratentorial intraventricular tumors depends on the extent of tumor resection

enthalten in: Acta neurochirurgica | 2023

von Teske, N. | Chiquillo-Domínguez, M. | Skrap, B. | +8

9

T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals

enthalten in: Blood | 2022

von Philipp, N. | Kazerani, M. | Nicholls, A. | +22

CommentIn: Blood. 2022 Sep 8;140(10):1056-1058. - PMID 36074532

10

Increased visceral fat distribution and body composition impact cytokine release syndrome onset and severity after CD19 chimeric antigen receptor T-cell therapy in advanced B-cell malignancies

enthalten in: Haematologica | 2022

von Dos Santos, D. | Rejeski, K. | Winkelmann, M. | +10